Korea BioNews
Total 367 Article , currentpage 30 /Total Page RSS
No | SUBJECT | SOURCE | DATE | COUNT |
---|---|---|---|---|
77 | [INTERVIEW] Matica to capitalize on growing cell and gene therapy CDMO market | Korea JoongAng Dail... | 2023-11-01 | 6 |
76 | Samsung Biologics announces plans for four new factories | Korea JoongAng Dail... | 2023-11-01 | 5 |
75 | Biotech companies share industry plans at J.P. Morgan Healthcare Conference | Korea JoongAng Dail... | 2023-11-01 | 8 |
74 | Korea’s bioindustry output surpasses $15 bn in 2021 on robust exports | Pulse | 2023-10-31 | 6 |
73 | K-bio names speed up biosim development for macular degeneration | Pulse | 2023-10-31 | 4 |
72 | CHA Vaccine Institute gains to conduct Phase 1 clinical test for Zoster vaccine | Pulse | 2023-10-31 | 7 |
71 | SillaJen readying for phase 1 trial of cancer drug licensed from Switzerland | Pulse | 2023-10-31 | 5 |
70 | Celltrion kicks off marketing of Avastin biosim in Korea | Pulse | 2023-10-31 | 6 |
69 | K-bio names speed up biosim development for macular degeneration | Pulse | 2023-10-31 | 7 |
68 | Korean small pharma stocks up on state’s cold medicine production order | Pulse | 2023-10-31 | 6 |